Dr. Martinez-Outshoorn

Ubaldo Martinez-Outshoorn, MD

Contact Dr. Martinez-Outshoorn

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 955-8874

Most Recent Peer-reviewed Publications

  1. Acquired uniparental disomy in chromosome 6p as a feature of relapse after T-cell replete haploidentical hematopoietic stem cell transplantation using cyclophosphamide tolerization
  2. EBV-associated peripheral t-cell lymphoma of gastrointestinal tract presented with widespread chronic inflammation: A case report
  3. TP53-inducible glycolysis and apoptosis regulator (TIGAR) metabolically reprograms carcinoma and stromal cells in breast cancer
  4. Multicompartment metabolism in papillary thyroid cancer
  5. Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells
  6. Cancer stem cell metabolism
  7. Cancer metabolism: a therapeutic perspective
  8. Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)
  9. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
  10. Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer
  11. A two-step approach to myeloablative haploidentical transplantation: Low nonrelapse mortality and high survival confirmed in patients with earlier stage disease
  12. Metastasis and Oxidative Stress: Are Antioxidants a Metabolic Driver of Progression?
  13. Caveolae and signalling in cancer
  14. Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
  15. Parathyroid Hormone-Related Peptide-Linked Hypercalcemia in a Melanoma Patient Treated with Ipilimumab: Hormone Source and Clinical and Metabolic Correlates
  16. Dissecting tumor metabolic heterogeneity: Telomerase and large cell size metabolically define a sub-population of stem-like, mitochondrial-rich, cancer cells
  17. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells
  18. Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy
  19. Prognostic Indications of Elevated MCT4 and CD147 across Cancer Types: A Meta-Analysis
  20. Mitochondrial mass, a new metabolic biomarker for stem-like cancer cells: Understanding WNT/FGF-driven anabolic signaling